Amedisys Cash Flow - Quarterly (NASDAQ:AMED)

Add to My Stocks
$57.79 $0.92 (1.62%) AMED stock closing price Feb 21, 2018 (Closing)

For analyzing any company like Amedisys from an investment perspective, its important to check the cash flow statement. While its important to look at the Amedisys debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Amedisys revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Amedisys stock analysis shows positive net income cash flow of $34.38M till 2017 Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Amedisys is $ 2017 Q3, which saw an increase from previous quarter.

View and download details of Amedisys cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
34.38M19.72M15.19M37.63M28.65M17.15M6.31M-2.31M-15.38M
Depreciation Depletion Amortization Cash-Flow13.69M9.32M4.6M20.41M15.21M9.81M4.65M20.99M16.57M
Net Increase (Decrease) in Assets Liabilities-29.66M1.8M-14.83M-67.07M-59.08M-31.4M-13.24M-18.34M-2.42M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net55.12M32.48M22.12M71.28M48.91M31.32M14.51M107.44M88.98M
Net Cash from (used by) Operating Activities
73.54M63.34M27.09M62.25M33.69M26.89M12.24M107.78M87.74M
Increase (Decrease) in Prop Plant And Equipment-8.33M-6.88M-4.38M-15.71M-13.5M-9.68M-6.7M-1.44M-17.96M
Acquisition Disposition of Subsidiaires-24.12M-24.12M-4.09M-35.52M-31.37M-27.63M-27.68M-68.71M-5.38M
Increase (Decrease) in Investments-0.43M-0.43M-0.25M-1.04M-0.75M-0.43M-1.51M2.43M
Other Cash Inflow (Outflow) from Investment Activities-------1.22M1.05M
Net Cash from (used by) Investment Activities
-32.89M-31.44M-8.17M-52.04M-45.4M-37.75M-34.15M-67.42M-19.85M
Issuance (Purchase) of Equity Shares-0.44M-0.33M--9.83M-10.49M-11.1M-11.67M-1.97M1.99M
Issuance (Repayment) of Debt Securities-4.06M-2.5M-1.25M-5M-3.75M-2.5M-1.25M-3M-3M
Increase (Decrease) in Bank & Other Borrowings------15M-15M-15M
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.21M-0.09M-0.04M7.31M7.36M6.93M--0.91M-2.85M
Net Cash from (used by) Financing Activities
-4.72M-2.92M-0.78M-7.51M-6.88M-6.67M2.23M-20.89M-18.86M
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
35.91M28.96M18.13M2.69M-18.58M-17.53M-19.67M19.47M49.01M
Cash & Equivalents at Beginning of Year27.5M8.03M17.3M14.54M48M120.29M34.48M2.84M56.19M
Cash & Equivalents at Year End66.11M59.16M48.33M30.19M8.91M9.96M7.82M27.5M57.05M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Amedisys stock price history provides insight into historical stock price fluctuations, and Amedisys stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Amedisys is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Amedisys stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $73.54M for AMED.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-32.89M for AMED stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-4.72M for Amedisys.

Key Financial Ratios For Amedisys Cash Flow

FCF margin
0.02

Quarterly Cash Flow Statements For Amedisys Inc Peers

Chemed cash flow, Civitas cash flow, Surgical Care Affiliates cash flow